Skip to main content

Table 9 Principal cause of presenting and best-corrected visual acuity< 20/63 in cataract-operated eyes. No. (%)

From: Ethnic variation in prevalence, self-reported barriers and outcome of cataract surgery in a rural population in southwestern China: the Yunnan minority eye study

Principal cause

Presenting visual acuity

Best-corrected visual acuity

Ethnicity

IOL status

Total

Ethnicity

IOL status

Total

Han

Bai

Yi

Aphakic

Pseudophakic

Han

Bai

Yi

Aphakic

Pseudophakic

Refractive error/uncorrected aphakia

22 (18.3)

22 (32.8)

22 (21.2)

18 (27.3)

48 (21.3)

66 (22.7)

8 (10.1)

0 (0)

2 (4.1)

8 (15.4)

2 (1.7)

10 (5.8)

Retinal disorder

35 (29.2)

15 (22.4)

29 (27.1)

15 (22.7)

63 (28.0)

78 (26.8)

28 (35.4)

14 (31.8)

23 (46.9)

13 (25.0)

52 (43.4)

65 (37.8)

Age-related macular degeneration

20 (16.7)

8 (11.9)

16 (15.4)

6 (9.1)

38 (16.9)

44 (15.1)

14 (17.7)

8 (18.2)

12 (24.5)

6 (11.5)

28 (23.3)

34 (19.8)

Macular epiretinal membrane

2 (1.7)

0 (0)

1 (1.0)

0 (0)

3 (1.3)

3 (1.0)

1 (1.3)

0 (0)

1 (2.0)

0 (0)

2 (1.7)

2 (1.2)

Macular hole

0 (0)

1 (1.5)

0 (0)

0 (0)

1 (0.4)

1 (0.3)

0 (0)

1 (2.3)

0 (0)

0 (0)

1 (0.8)

1 (0.6)

Retinal detachment

3 (2.5)

1 (1.5)

3 (2.9)

2 (3.0)

5 (2.2)

7 (2.4)

3 (3.8)

1 (2.3)

3 (6.1)

2 (3.8)

5 (4.2)

7 (4.1)

Angiogenic retinopathy

1 (0.8)

0 (0)

0 (0)

0 (0)

1 (0.4)

1 (0.3)

1 (1.3)

0 (0)

0 (0)

0 (0)

1 (0.8)

1 (0.6)

Diabetic retinopathy

1 (0.8)

0 (0)

0 (0)

0 (0)

1 (0.4)

1 (0.3)

1 (1.3)

0 (0)

0 (0)

0 (0)

1 (0.8)

1 (0.6)

Proliferative vitreoretinopathy

0 (0)

0 (0)

2 (1.9)

2 (3.0)

0 (0)

2 (0.7)

0 (0)

0 (0)

1 (2.0)

1 (1.9)

0 (0)

1 (0.6)

Retinitis pigmentosa

2 (1.7)

0 (0)

1 (1.0)

0 (0)

3 (1.3)

3 (1.0)

2 (2.5)

0 (0)

1 (2.0)

0 (0)

3 (2.5)

3 (1.7)

Vitreous haze

0 (0)

2 (3.0)

0 (0)

2 (3.0)

0 (0)

2 (0.7)

0 (0)

2 (4.5)

0 (0)

2 (3.8)

0 (0)

2 (1.2)

High myopic retinopathy

6 (5.0)

3 (4.5)

6 (5.0)

3 (4.5)

11 (4.9)

14 (4.8)

6 (7.6)

2 (4.5)

5 (10.2)

2 (3.8)

11 (9.2)

13 (7.6)

Posterior capsule opacification

30 (25.0)

5 (7.5)

38 (36.5)

4 (6.1)

69 (30.7)

73 (25.1)

12 (15.2)

5 (11.4)

11 (22.4)

3 (5.8)

25 (20.8)

28 (16.3)

Glaucoma

12 (10.0)

10 (14.9)

5 (4.8)

8 (12.1)

19 (8.4)

27 (9.3)

11 (13.9)

10 (22.7)

4 (8.2)

8 (15.4)

17 (14.2)

25 (14.5)

Optic atrophy

10 (8.3)

8 (11.9)

5 (4.8)

13 (19.7)

10 (4.4)

23 (7.9)

9 (11.4)

8 (18.2)

4 (8.2)

12 (23.1)

9 (7.5)

21 (12.2)

Corneal opacity/scar

5 (4.2)

1 (1.5)

3 (2.9)

4 (6.1)

5 (2.2)

9 (3.1)

5 (6.3)

1 (2.3)

3 (6.1)

4 (7.7)

5 (4.2)

9 (5.2)

Pterygium

2 (1.7)

4 (6.0)

1 (1.0)

2 (3.0)

5 (2.2)

7 (2.4)

2 (2.5)

4 (9.1)

0 (0)

2 (3.8)

4 (3.3)

6 (3.5)

Uveitis

2 (1.7)

0 (0)

1 (1.0)

1 (1.5)

2 (0.9)

3 (1.0)

2 (2.5)

0 (0)

1 (2.0)

1 (1.9)

2 (1.7)

3 (1.7)

amblyopia

1 (0.8)

0 (0)

0 (0)

0 (0)

1 (0.4)

1 (0.3)

1 (1.3)

0 (0)

0 (0)

0 (0)

1 (0.8)

1 (0.6)

Other cause

1 (0.8)

1 (1.5)

0 (0)

1 (1.5)

1 (0.4)

2 (0.7)

1 (1.3)

1 (2.3)

0 (0)

1 (1.9)

1 (0.8)

2 (1.2)

Undetermined

0 (0)

1 (1.5)

1 (1.0)

0 (0)

2 (0.9)

2 (0.7)

0 (0)

1 (2.3)

1 (2.0)

0 (0)

2 (1.7)

2 (1.2)

Total

120 (100.0)

67 (100.0)

104 (100.0)

66 (100.0)

225 (100.0)

291 (100.0)

79 (100.0)

44 (100.0)

49 (100.0)

52 (100.0)

120 (100.0)

172 (100.0)